The tumours derived from Gd@C82(OH)22-treated groups exhibited significantly less Ki-67-labelled cells (Supplementary Fig. 7d–f), but no significant changes were observed in the number of active-caspase-3-labelled cells (Supplementary Fig. 7g–i) compared with control tumours. This evidence concerns the gene CASP3 and neoplasm.